Share

Clinical Studies (1)

  • Kuzubov : Study aims to assess the immunogenicity, reactogenicity and safety of the VAC?6 vaccine in healthy volunteers aged 18-60 years

Study Data

  • Adults (18-64 years)
  • General population
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • VAC∆6

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to